Serum transthyretin before and after starting tafamidis as outcome predictors in ATTR cardiomyopathy

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Contemporary biomarkers for diagnosis, monitoring, and prognosis in heart failure Biomarkers Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by